- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00422474
Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke
Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis
After acute stroke, baroreflex sensitivity (BRS) is impaired. This impaired acute stage BRS has been reported to be predictive of worsen outcome years after stroke in general. However, it is not very clear if the impaired acute stroke BRS would actually persist months after the acute stage. It is also not clear that such change, if any, would correlate with the functional outcome or prognosis after stroke.
The trial is to investigate the longitudinal time course of BRS after ischemic stroke up to the 6th month post stroke and to see if there is any correlation of the changes in BRS with the functional outcome parameters using NIHSS and mRS scores throughout this period.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Taipei County
-
Panchiao City, Taipei County, Taiwan, 220
- Recruiting
- Far Eastern Memorial Hospital
-
Contact:
- Siupak Lee, M.D.
- Email: siupakmd@ms1.hinet.net
-
Principal Investigator:
- Siupak Lee, M.D.
-
Sub-Investigator:
- Lung Chan, M.D.
-
Sub-Investigator:
- Dong-feng Yeih, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Baroreflex sensitivity can be done within 72 hours of onset of acute ischemic stroke
- 50-80 years old
- Must have either brain CT or brain MRI done
Exclusion Criteria:
- NIHSS score > 10
- Patient could not cooperate
- Unstable vital sign
- Atrial fibrillation
- Transient ischemic attack patient
- Diabetic patient
- Impaired renal function (Cr > 2.26 mg/dl)
- Unstable angina, acute myocardiac infarction, cardiomyopathy patients
- Patient who has known autonomic dysfunction
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Siupak Lee, M.D., Far Eastern Memorial Hospital
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FEMH-95-C-012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.